Literature DB >> 26112990

Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.

Chu-wen Lin1,2, Xiao-li Huang1,2, Hai-lin Liu1,2, Yan Wang3.   

Abstract

Hepatitis B virus (HBV) infection is a major etiology of chronic liver disease worldwide. In the past decade, nonalcoholic fatty liver disease (NAFLD) has emerged as a common liver disorder in general population. Accordingly, the patient number of chronic hepatitis B (CHB) concomitant with NAFLD grows rapidly. The present article reviewed the recent studies aiming to explore the relationship between CHB and NAFLD from different aspects, including the relevant pathogenesis of CHB and NAFLD, the intracellular molecular mechanisms overlaying HBV infection and hepatic steatosis, and the observational studies with animal models and clinical cohorts for analyzing the coincidence of the two diseases. It is concluded that although numerous cross-links have been suggested between the molecular pathways in HBV infection and NAFLD pathogenesis, regarding whether HBV infection can substantially interfere with the occurrence of NAFLD or vice versa in the patients, there is still far from a conclusive agreement.

Entities:  

Keywords:  Association; Coincidence; Hepatitis B virus infection; Nonalcoholic fatty liver disease

Mesh:

Year:  2015        PMID: 26112990     DOI: 10.1007/s10620-015-3772-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  113 in total

Review 1.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

2.  ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolism.

Authors:  Heidi Peters; Nicole Buck; Ronald Wanders; Jos Ruiter; Hans Waterham; Janet Koster; Joy Yaplito-Lee; Sacha Ferdinandusse; James Pitt
Journal:  Brain       Date:  2014-08-14       Impact factor: 13.501

3.  HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways.

Authors:  Ji Yeon Kim; Eun Hyun Song; Hyun Jung Lee; Yeo Kyoung Oh; Kyung-Hee Choi; Dae-Yeul Yu; Sang Ick Park; Je-Kyung Seong; Won-Ho Kim
Journal:  J Mol Biol       Date:  2010-02-13       Impact factor: 5.469

4.  Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.

Authors:  M Stepanova; B Lam; Y Younossi; M K Srishord; Z M Younossi
Journal:  J Viral Hepat       Date:  2011-11-09       Impact factor: 3.728

5.  Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Authors:  Alexander Ploss; Salman R Khetani; Christopher T Jones; Andrew J Syder; Kartik Trehan; Valeriya A Gaysinskaya; Kathy Mu; Kimberly Ritola; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

6.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.

Authors:  Johan Westin; Hans Nordlinder; Martin Lagging; Gunnar Norkrans; Rune Wejstål
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

7.  Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.

Authors:  Zheng Zhang; Qin Pan; Xiao-Yan Duan; Qiang Liu; Guo-Yu Mo; Gui-Rong Rao; Jian-Gao Fan
Journal:  J Gastroenterol Hepatol       Date:  2012-12       Impact factor: 4.029

8.  Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Meihua Wang; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.

Authors:  Jung Won Yun; Yong Kyun Cho; Jung Ho Park; Hong Joo Kim; Dong Il Park; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Byung Ho Son; Jun Ho Shin
Journal:  Liver Int       Date:  2009-01-22       Impact factor: 5.828

10.  A genetically humanized mouse model for hepatitis C virus infection.

Authors:  Marcus Dorner; Joshua A Horwitz; Justin B Robbins; Walter T Barry; Qian Feng; Kathy Mu; Christopher T Jones; John W Schoggins; Maria Teresa Catanese; Dennis R Burton; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

View more
  15 in total

1.  Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.

Authors:  Liguo Zhu; Jie Jiang; Xiangjun Zhai; Aileen Baecker; Hong Peng; Jiao Qian; MingHao Zhou; Ci Song; Yan Zhou; Jianfang Xu; Hongjian Liu; Dong Hang; Zhibin Hu; Hongbin Shen; Zuo-Feng Zhang; Fengcai Zhu
Journal:  Liver Int       Date:  2018-08-19       Impact factor: 5.828

2.  Liver enzymes and fibrosis markers in patients with non-alcoholic fatty liver disease and concomitant chronic viral hepatitis.

Authors:  Micah Grubert Van Iderstine; J Uhanova; Gerald Y Minuk
Journal:  Can Liver J       Date:  2021-08-09

3.  Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

Authors:  Joo Hyun Oh; Hye Won Lee; Dong Hyun Sinn; Jun Yong Park; Beom Kyung Kim; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Wonseok Kang; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Yong-Han Paik
Journal:  Hepatol Int       Date:  2021-07-14       Impact factor: 6.047

Review 4.  The Effect of Hepatosteatosis on Response to Antiviral Treatment in Patients with Chronic Hepatitis B: A Meta-Analysis.

Authors:  Yongfen Zhu; Qiao Yang; Fangfang Lv; Yunsong Yu
Journal:  Gastroenterol Res Pract       Date:  2017-03-21       Impact factor: 2.260

5.  Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study.

Authors:  Yangqin Chen; Chunlei Fan; Yuhan Chen; Hui Liu; Shanshan Wang; Peiling Dong; Lei Li; Huiguo Ding
Journal:  Oncotarget       Date:  2017-04-24

6.  Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease.

Authors:  Geng-Lin Zhang; Qi-Yi Zhao; Chao-Shuang Lin; Zhao-Xia Hu; Ting Zhang; Zhi-Liang Gao
Journal:  Biomed Res Int       Date:  2019-01-23       Impact factor: 3.411

7.  Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B.

Authors:  Mindie H Nguyen; Joseph K Lim; A Burak Ozbay; Jeremy Fraysse; Iris Liou; Nicole Meyer; Geoffrey Dusheiko; Stuart C Gordon
Journal:  Hepatology       Date:  2019-02-11       Impact factor: 17.425

8.  Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case-Control Study.

Authors:  Ghodsiyeh Azarkar; Zahra Doosti; Freshteh Osmani; Masood Ziaee
Journal:  Hepat Med       Date:  2019-10-25

9.  Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease.

Authors:  Geng-Lin Zhang; Shi-Cheng Xu; Jie Zeng; Zheng Chen; Yi-Ping Li; Ting Zhang; Zhi-Liang Gao
Journal:  Dis Markers       Date:  2019-12-05       Impact factor: 3.434

10.  High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.

Authors:  Tse-Ling Fong; Naranbaatar D Dashdorj; Takeshi Saito; Brian T Lee; Mimi Chang; Khishigsuren Nasanbayar; Enkhjargal Tsogtoo; Delgerbat Boldbaatar; Esugen D Dashdorj; Namuun E Clifford; Arghun N Dashdorj; Bo-Ram Bang; Takeshi Chida; Carolina Lim; Masaya Sugiyama; Masashi Mizokami; Naranjargal J Dashdorj; Ping Liu; Jeffrey S Glenn
Journal:  Dig Dis Sci       Date:  2020-08-08       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.